Cormorant Asset Management, LP: 13F holdings
CIK 15839772026Q2
| Positions | 50 |
|---|---|
| Reported value | $2.0bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 640,000 | $214.3m | 11.0% |
| BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $136.2m | 7.0% |
| PARABILIS MEDICINES INC | 4,615,612 | $126.3m | 6.5% |
| RAPPORT THERAPEUTICS INC | 2,657,521 | $110.7m | 5.7% |
| ERASCA INC | 6,000,000 | $109.9m | 5.6% |
| EWTX EDGEWISE THERAPEUTICS INC | 2,510,000 | $102.0m | 5.2% |
| EYEPOINT INC | 7,000,000 | $100.1m | 5.1% |
| ALUMIS INC | 3,285,596 | $92.5m | 4.7% |
| ABIVAX SA | 675,000 | $90.0m | 4.6% |
| DIANTHUS THERAPEUTICS INC | 750,000 | $73.1m | 3.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1583977")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.